THERIVA BIOLOGICS INC (TOVX) Stock Analyst Ratings
USA - NYSEARCA:TOVX - US87164U5083 - Common Stock
0.2738 USD
-0.02 (-5.59%)
ChartMill assigns a Buy % Consensus number of 80% to TOVX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 2507.74% above the current price.
TOVX was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TOVX.
In the previous month the buy percentage consensus was at a similar level.
TOVX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-08 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-11-13 | Maxim Group | Maintains | Buy -> Buy |
THERIVA BIOLOGICS INC / TOVX FAQ
What is the average price target for THERIVA BIOLOGICS INC (TOVX) stock?
8 analysts have analysed TOVX and the average price target is 7.14 USD. This implies a price increase of 2507.74% is expected in the next year compared to the current price of 0.2738.
What is the consensus rating for THERIVA BIOLOGICS INC (TOVX) stock?
The consensus rating for THERIVA BIOLOGICS INC (TOVX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.